Skip to main content

Table 1 Descriptive measurements of IGF-I measured prior to and following 28 days of raloxifene treatment

From: Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene

SerumIGF-I levels

Mean

S. E.

Minimum

Maximum

Before treatment

143.7

9.7

77.1

224.0

After treatment

94.8*

7.6

41.9

190.0

  1. * The difference was statistically significant (p < 0.001).